Alcon AG
ALC78.800USD
0.000
Cierre 12/15, 16:00（ET）Cotizaciones retrasadas 15 min
38.97BCap. mercado
37.22P/E TTM
Más Datos de Alcon AG Compañía
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Información de Alcon AG
Símbolo de cotizaciónALC
Nombre de la empresaAlcon AG
Fecha de salida a bolsaApr 09, 2019
Director ejecutivoEndicott (David J)
Número de empleados25599
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 09
DirecciónRue Louis d'Affry 6
CiudadFRIBOURG
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísSwitzerland
Código postal1700
Teléfono41589113800
Sitio Webhttps://www.alcon.ch/
Símbolo de cotizaciónALC
Fecha de salida a bolsaApr 09, 2019
Director ejecutivoEndicott (David J)
Ejecutivos de Alcon AG
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
Por regiónUSD
Nombre
Ganancia
Proporción
International
1.42B
54.99%
United States
1.16B
45.01%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
Estadísticas de accionistas
Actualizado: jue., 27 de nov
Actualizado: jue., 27 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
Otro
84.16%
Accionistas
Accionistas
Proporción
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
Otro
84.16%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
31.53%
Investment Advisor/Hedge Fund
24.78%
Bank and Trust
4.10%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.09%
Research Firm
1.93%
Pension Fund
1.41%
Individual Investor
0.13%
Insurance Company
0.07%
Otro
31.62%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1623
342.44M
72.26%
+507.76K
2025Q3
1664
342.40M
72.42%
-9.24M
2025Q2
1658
350.50M
70.82%
+3.47M
2025Q1
1649
340.47M
77.49%
-46.78M
2024Q4
1637
370.92M
68.31%
+36.10M
2024Q3
1614
334.31M
67.55%
+3.20M
2024Q2
1581
336.83M
74.41%
-28.77M
2024Q1
1567
336.16M
66.45%
+4.09M
2023Q4
1583
325.43M
67.42%
+1.37M
2023Q3
1565
323.23M
69.34%
-9.13M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
Zürcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Select Equity Group, L.P.
6.76M
1.35%
+1.28M
+23.44%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Global X Aging Population ETF
2.36%
Franklin FTSE Switzerland ETF
2.28%
iShares MSCI Switzerland ETF
2.2%
First Trust Indxx Medical Devices ETF
2.06%
Running Oak Efficient Growth ETF
1.77%
Global X S&P Catholic Values Developed ex-US ETF
1.07%
JPMorgan BetaBuilders Europe ETF
0.59%
iShares Global Healthcare ETF
0.53%
ALPS O'Shares International Developed Quality Dividend ETF
0.45%
Wahed Dow Jones Islamic World ETF
0.44%
Ver más
Global X Aging Population ETF
Proporción2.36%
Franklin FTSE Switzerland ETF
Proporción2.28%
iShares MSCI Switzerland ETF
Proporción2.2%
First Trust Indxx Medical Devices ETF
Proporción2.06%
Running Oak Efficient Growth ETF
Proporción1.77%
Global X S&P Catholic Values Developed ex-US ETF
Proporción1.07%
JPMorgan BetaBuilders Europe ETF
Proporción0.59%
iShares Global Healthcare ETF
Proporción0.53%
ALPS O'Shares International Developed Quality Dividend ETF
Proporción0.45%
Wahed Dow Jones Islamic World ETF
Proporción0.44%
Dividendos
Un total de
400.00M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Alcon AG?
Los cinco principales accionistas de Alcon AG son:
BlackRock Advisors (UK) Limited posee 24.68M acciones, lo que representa el 4.94% del total de acciones.
The Vanguard Group, Inc. posee 20.64M acciones, lo que representa el 4.13% del total de acciones.
UBS Fund Management (Switzerland) AG posee 11.47M acciones, lo que representa el 2.29% del total de acciones.
Norges Bank Investment Management (NBIM) posee 11.35M acciones, lo que representa el 2.27% del total de acciones.
Aristotle Capital Management, LLC posee 12.04M acciones, lo que representa el 2.41% del total de acciones.
BlackRock Advisors (UK) Limited posee 24.68M acciones, lo que representa el 4.94% del total de acciones.
The Vanguard Group, Inc. posee 20.64M acciones, lo que representa el 4.13% del total de acciones.
UBS Fund Management (Switzerland) AG posee 11.47M acciones, lo que representa el 2.29% del total de acciones.
Norges Bank Investment Management (NBIM) posee 11.35M acciones, lo que representa el 2.27% del total de acciones.
Aristotle Capital Management, LLC posee 12.04M acciones, lo que representa el 2.41% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Alcon AG?
Los tres principales tipos de accionista de Alcon AG son:
BlackRock Advisors (UK) Limited
The Vanguard Group, Inc.
UBS Fund Management (Switzerland) AG
BlackRock Advisors (UK) Limited
The Vanguard Group, Inc.
UBS Fund Management (Switzerland) AG
¿Cuántas instituciones poseen acciones de Alcon AG (ALC)?
A fecha de 2025Q4, 1623 instituciones poseen acciones de Alcon AG, con un valor de mercado combinado de aproximadamente 342.44M, lo que representa el 72.26% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.16%.
¿Cuál es la mayor fuente de ganancias de Alcon AG?
El FY2025Q2, el segmento empresarial Consumables generó la ganancia más alta para Alcon AG, ascendiendo a 777.00M y representando el 30.15% de la ganancia total.
